Anika Therapeutics Inc - Common Stock (ANIK)

CUSIP: 035255108

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock
Shares outstanding
13,404,566
Total 13F shares
13,404,303
Share change
+136,070
Total reported value
$340,492,164
Put/Call ratio
107%
Price per share
$25.40
Number of holders
119
Value change
+$4,319,363
Number of buys
52
Number of sells
52

Quarterly Holders Quick Answers

What is CUSIP 035255108?
CUSIP 035255108 identifies ANIK - Anika Therapeutics Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ANIK - Anika Therapeutics Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Trigran Investments, Inc.
13F
Company
16%
2,139,054
$48,470,964 31 Dec 2023
13F
BlackRock Finance, Inc.
13F
Company
10%
1,383,877
$31,358,653 31 Dec 2023
13F
Caligan Partners LP
13F
Company
8.1%
1,081,360
$24,503,618 31 Dec 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
6.1%
821,452
$18,614,101 31 Dec 2023
13F
VANGUARD GROUP INC
13F
Company
5.7%
764,045
$17,313,259 31 Dec 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
4.2%
564,329
$12,788,000 31 Dec 2023
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
3.8%
509,522
$11,545,769 31 Dec 2023
13F
MORGAN STANLEY
13F
Company
3.6%
485,093
$10,992,207 31 Dec 2023
13F
CAPITAL MANAGEMENT CORP /VA
13F
Company
2.7%
355,534
$8,056,400 31 Dec 2023
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
2.5%
334,991
$7,587,000 31 Dec 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
2.4%
327,642
$7,424,368 31 Dec 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.4%
318,913
$7,227,356 31 Dec 2023
13F
STATE STREET CORP
13F
Company
2.3%
309,041
$7,002,869 31 Dec 2023
13F
Nuveen Asset Management, LLC
13F
Company
2%
265,476
$6,015,686 31 Dec 2023
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
1.7%
222,510
$5,042,000 31 Dec 2023
13F
Invenomic Capital Management LP
13F
Company
1.6%
210,332
$4,766,123 31 Dec 2023
13F
Alta Fundamental Advisers LLC
13F
Company
1.4%
192,544
$4,363,047 31 Dec 2023
13F
CITADEL ADVISORS LLC
13F
Company
1.4%
189,450
$4,292,937 31 Dec 2023
13F
D. E. Shaw & Co., Inc.
13F
Company
1.3%
169,244
$3,835,069 31 Dec 2023
13F
NORTHERN TRUST CORP
13F
Company
1%
137,420
$3,113,937 31 Dec 2023
13F
FRANKLIN RESOURCES INC
13F
Company
1%
133,611
$3,027,626 31 Dec 2023
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.92%
123,095
$2,789,333 31 Dec 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.88%
118,157
$2,677,438 31 Dec 2023
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.7%
94,151
$2,133,462 31 Dec 2023
13F
DEUTSCHE BANK AG\
13F
Company
0.61%
82,056
$1,859,389 31 Dec 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.6%
80,742
$1,829,614 31 Dec 2023
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
0.58%
77,900
$1,765,214 31 Dec 2023
13F
Michael L. Levitz
3/4/5
EVP, CFO, Treasurer
mixed-class rows
119,966
mixed-class rows
$1,761,044 15 Mar 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.5%
66,563
$1,508,318 31 Dec 2023
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.46%
62,283
$1,411,333 31 Dec 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.45%
60,264
$1,365,582 31 Dec 2023
13F
Squarepoint Ops LLC
13F
Company
0.44%
58,555
$1,326,856 31 Dec 2023
13F
Trexquant Investment LP
13F
Company
0.44%
58,463
$1,324,772 31 Dec 2023
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.44%
58,376
$1,323,000 31 Dec 2023
13F
OSAIC HOLDINGS, INC.
13F
Company
0.42%
56,863
$1,288,409 31 Dec 2023
13F
DIKER MANAGEMENT LLC
13F
Company
0.42%
56,239
$1,274,376 31 Dec 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.42%
56,173
$1,272,880 31 Dec 2023
13F
Bank of New York Mellon Corp
13F
Company
0.41%
55,479
$1,257,155 31 Dec 2023
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.39%
52,642
$1,192,868 31 Dec 2023
13F
ROYAL BANK OF CANADA
13F
Company
0.39%
52,198
$1,183,000 31 Dec 2023
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.38%
51,011
$1,155,909 31 Dec 2023
13F
Meros Investment Management, LP
13F
Company
0.37%
49,949
$1,131,844 31 Dec 2023
13F
Assenagon Asset Management S.A.
13F
Company
0.35%
47,024
$1,065,564 31 Dec 2023
13F
Virtus Investment Advisers, LLC
13F
Company
0.34%
45,579
$1,032,820 31 Dec 2023
13F
HRT FINANCIAL LP
13F
Company
0.31%
40,916
$927,000 31 Dec 2023
13F
Cubist Systematic Strategies, LLC
13F
Company
0.29%
39,518
$895,478 31 Dec 2023
13F
Fisher Asset Management, LLC
13F
Company
0.29%
38,620
$875,128 31 Dec 2023
13F
BARCLAYS PLC
13F
Company
0.28%
37,826
$857,137 31 Dec 2023
13F
GLOBEFLEX CAPITAL L P
13F
Company
0.26%
35,500
$804,430 31 Dec 2023
13F
Susquehanna Portfolio Strategies, LLC
13F
Company
0.24%
31,676
$717,778 31 Dec 2023
13F

Institutional Holders of Anika Therapeutics Inc - Common Stock (ANIK) as of Q1 2024

As of 31 Mar 2024, Anika Therapeutics Inc - Common Stock (ANIK) was held by 119 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,404,303 shares. The largest 10 holders included Trigran Investments, Inc., BlackRock Inc., Caligan Partners LP, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, BOOTHBAY FUND MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, and CAPITAL MANAGEMENT CORP /VA. This page lists 119 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
116
Q1 2024 holders
119
Holder diff
3
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 Value $ Q1 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .